Thanks to advances in molecular sequencing, scientists have generated a wealth of data from the genome, transcriptome, proteome and metabolome. However, these "-omics" datasets are complex and there ...
New analysis of PARTNER trial data shows that, even after extensive adjustment, there are differences in outcomes between transapical and transfemoral TAVR for high-risk and inoperable patients with ...
Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax personalized immune therapies for solid ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
Please provide your email address to receive an email when new articles are posted on . It has become much harder to be a rational person with a modicum of biostatistical knowledge who can refrain ...
Northwest Biotherapeutics (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that Dr. Marnix Bosch, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results